Sunday, March 16, 2025 | 07:36 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Sequent Scientific plans to sell Specialty Chemicals Division

Transfer is subject to the approval of the shareholders of the company

ImageBS B2B Bureau B2B Connect | Mumbai
Image

The Bangalore-based Sequent Scientific Ltd, a fully integrated pharmaceutical company, has informed BSE that the Board of Directors of the company has approved the transfer of Specialty Chemicals Division along with all related assets and liabilities of the company by way of slump sale to any company/entity/or any other person.
 
The above said transfer is subject to the approval of the shareholders of the company.
 
SeQuent, which has a presence in different pharmaceutical verticals as well as specialty chemicals, recently signed an joint venture agreement with the Chennai based Shasun Pharmaceuticals to develop, manufacture and sell veterinary products including active pharmaceutical ingredients (APIs) and formulations in the global market.

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 13 2014 | 3:59 PM IST

Explore News